- Home
- DNLI vs VTMX Comparison
DNLI vs VTMX Comparison
Compare DNLI & VTMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DNLI
- VTMX
- Stock Information
- Founded
- DNLI 2013
- VTMX 1998
- Country
- DNLI United States
- VTMX Mexico
- Employees
- DNLI N/A
- VTMX N/A
- Industry
- DNLI Biotechnology: Biological Products (No Diagnostic Substances)
- VTMX
- Sector
- DNLI Health Care
- VTMX
- Exchange
- DNLI Nasdaq
- VTMX Nasdaq
- Market Cap
- DNLI 2.1B
- VTMX 2.4B
- IPO Year
- DNLI 2017
- VTMX 2023
- Fundamental
- Price
- DNLI $15.42
- VTMX $27.03
- Analyst Decision
- DNLI Strong Buy
- VTMX Sell
- Analyst Count
- DNLI 15
- VTMX 2
- Target Price
- DNLI $33.50
- VTMX $29.50
- AVG Volume (30 Days)
- DNLI 2.1M
- VTMX 117.1K
- Earning Date
- DNLI 11-05-2025
- VTMX 10-23-2025
- Dividend Yield
- DNLI N/A
- VTMX 2.50%
- EPS Growth
- DNLI N/A
- VTMX N/A
- EPS
- DNLI N/A
- VTMX 0.04
- Revenue
- DNLI N/A
- VTMX $263,061,301.00
- Revenue This Year
- DNLI N/A
- VTMX $12.94
- Revenue Next Year
- DNLI $95,463.19
- VTMX $10.26
- P/E Ratio
- DNLI N/A
- VTMX $68.66
- Revenue Growth
- DNLI N/A
- VTMX 11.49
- 52 Week Low
- DNLI $10.57
- VTMX $21.30
- 52 Week High
- DNLI $33.33
- VTMX $30.07
- Technical
- Relative Strength Index (RSI)
- DNLI 62.72
- VTMX 42.62
- Support Level
- DNLI $12.58
- VTMX $27.49
- Resistance Level
- DNLI $15.75
- VTMX $28.60
- Average True Range (ATR)
- DNLI 0.68
- VTMX 0.64
- MACD
- DNLI 0.24
- VTMX -0.02
- Stochastic Oscillator
- DNLI 89.59
- VTMX 36.69
About DNLI Denali Therapeutics Inc.
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.
About VTMX Corporacion Inmobiliaria Vesta S.A.B de C.V. each representing ten (10)
Corporacion Inmobiliaria Vesta SAB de CV is an internally managed real estate company that owns, manages, develops, and leases industrial properties in Mexico. The Company's primary business is the acquisition, development, and management of industrial and distribution center real estate. The company designs and constructs park-to-suit projects across various industries; undertakes build-to-suit projects; and provides site selection, design and engineering, and sale and leaseback services. The primary source of revenue is the rental income received from customers under operating leases. It serves aerospace, automotive, food and beverage, logistics, medical devices, plastics, and other industries.